by TractManager | Apr 29, 2024 | Emerging Technology Report
The FSYX Ocular Pressure Adjusting Pump (Balance Ophthalmics Inc.) is an investigational negative pressure eye goggle intended for adjunctive therapy to reduce nocturnal intraocular pressure in patients with open-angle glaucoma and normal daytime intraocular...
by TractManager | Apr 26, 2024 | Emerging Technology Report
Fidanacogene elaparvovec-dzkt (Beqvez; Pfizer Inc.) is a single-infusion gene therapy for the treatment of adults with moderate to severe hemophilia B who currently use factor IX prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have...
by TractManager | Apr 25, 2024 | Emerging Technology Report
The Ventura Interatrial Shunt (V-Wave Ltd.) is an investigational transcatheter interatrial shunt proposed for treatment of chronic heart failure.
by TractManager | Apr 24, 2024 | Emerging Technology Report
Rusfertide (formerly PTG-300; Protagonist Therapeutics Inc./Takeda Pharmaceutical Co. Ltd.) is a subcutaneously injected hepcidin mimetic for the treatment of erythrocytosis associated with polycythemia vera.
by TractManager | Apr 23, 2024 | Emerging Technology Report
Letetresgene autoleucel is an investigational autologous engineered T-cell therapy for the treatment of HLA-A*02 positive patients with advanced synovial sarcoma expressing the NY-ESO-1 antigen.
Recent Comments